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Abstract
The three neurexins genes (NRXN1/2/3) encode polymorphic synaptic membrane proteins that are involved in cognitive
functioning. Neurexins’ selectivity of function is presumably conferred through differential use of 2 promoters and 5
alternative splicing sites (SS#1/2/3/4/5). In day-old rat brain neurons grown in culture, activation (depolarization) induces
reversible, calcium dependent, repression of NRXN2a SS#3 insert. The effects of depolarization on NRXN1/2/3a splicing and
biochemical pathways mediating them were further studied in these neurons. NRXN1/2/3a splicing in the course of memory
formation in vivo was also explored, using fear conditioning paradigm in rats in which the animals were trained to associate
an aversive stimulus (electrical shock) with a neutral context (a tone), resulting in the expression of fear responses to the
neutral context. In the cultured neurons depolarization induced, beside NRXN2a SS#3, repression of SS#3 and SS#4 exons
in NRXN3a but not NRXN1a. The repressions were mediated by the calcium/protein kinase C/Rho-associated protein kinase
(ROCK) pathway. Fear conditioning induced significant and transient repressions of the NRXN1/2/3a SS#4 exons in the rat
hippocampus. ROCK inhibition prior to training attenuated the behavioral fear response, the NRXN1/2/3a splicing
repressions and subsequent recovery and the levels of excitatory (PSD95) and inhibitory (gephyrin) synaptic proteins in the
hippocampus. No such effects were observed in the prefrontal cortex. Significant correlations existed between the fear
response and hippocampal NRXN3a and NRXN2a SS#4 inserts as well as PSD95 protein levels. Hippocampal NRXN1a SS#4
insert and gephyrin levels did not correlate with the behavioral response but were negatively correlated with each
other. These results show for the first time dynamic, experience related changes in NRXN1/2/3a alternative splicing in the
rat brain and a role for ROCK in them. Specific neurexins’ transcripts may be involved in synaptic remodeling occurring at an
intermediate (hours) time scale in the course of memory formation.
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Introduction
Mammalian neurexins are highly polymorphic, primarily
synaptic proteins that are transcribed from three unlinked
neurexins genes, designated NRXN1, NRXN2 and NRXN3,
each transcribed from 2 promoters to yield longer (a) and shorter
(b) forms. All a-neurexins are variably spliced at five sites, referred
to as SS# 1 to 5 whereas the shorter b-neurexins contain only
SS#4 and 5 which may give rise to thousands of different
transcripts [1,2,3]. Alterations in genes encoding neurexins have
been implicated in diseases such as autism, schizophrenia and
addiction [4].
Binding of neurexins to certain synaptic proteins (i.e. neuroli-
gins, leucine-rich repeat transmembrane neuronal proteins
(LRRTMs), GABAA receptors and Cbln1/Glutamate receptor
delta2 (GluRd2) form trans-synaptic complexes which regulate
glutamatergic and GABA-ergic transmission and subsequently the
excitatory/inhibitory balance in brain networks [5–10]. There is
emerging evidence that certain neurexins polymorphs may
differentially bind to such ligands and presumably affect their
trans-synaptic properties. Whereas neuroligins bind neurexins
containing or lacking SS#4 insert, LRRTMs 1 and 2 and GluRd2
interact specifically with a and b neurexins lacking an insert at
SS#4 [5]. Alpha-neurexins containing the insert in SS#4 may
mediate GABA-ergic synaptic protein recruitment and stabiliza-
tion [10]. However, despite their apparent significance for
maintaining the synaptic excitatory-inhibitory balance, very little
is known about the dynamics of NRXN1/2/3 splicing patterns,
mechanisms that regulate them and the functional outcomes of
such.
Depolarization of neurons for 6 to 24 hours has been shown to
affect splicing patterns of a number of genes encoding synaptic
proteins [11]. We have recently observed that depolarization
selectively repressed NRXN2a SS#3 splicing in primary cultures
of cortical neurons leading to decrease in exon 11 (E11) included
transcripts. E11 NRXN2a splicing repression was time dependent,
reaching a maximum within 6 hours, and reversible, recovering
baseline levels of E11-included transcripts within 6 hours after
removal of the depolarizing medium. Cell viability was not
affected under these conditions [12]. NRXN2a splicing repression
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2+ dependent and completely abolished in the presence of
BAPTA-AM, a chelating agent that lowers intracellular Ca
2+
[12].
Considering the role of NRXN1a and NRXN3a in mental
health and cognitive functioning it was pertinent to ask whether
neuronal activation would affect their splicing patterns as well. In
the present study we investigated the alternative splicing of the two
other neurexins in the depolarized neurons and found selective
and reversible splicing repression at both SS#3 (E11) and SS#4
(E20) in NRXN3a but not in NRXN1a. The downstream
pathways controlling E11 splicing repression in NRXN2a and
NRXN3a and E20 splicing repression in NRXN3a were then
explored using pharmacological agents which inhibit or activate
specifics intracellular mechanisms, focusing on calcium regulated
pathways. These experiments demonstrated the involvement of
the calcium/protein kinase C (PKC)/Rho-associated protein
kinase (ROCK) pathway in the splicing repression.
Emerging evidence link the ROCK pathway to the expression
of anxiety- and fear-related behavior [13,14]. Different studies
have shown the involvement of the hippocampus and the
prefrontal cortex in fear conditioning [15]. We therefore used
fear conditioning paradigm to study potential experience depen-
dent effects on NRXN1/2/3a expression and splicing in the
course of memory formation in the rat brain, focusing on the
hippocampus and prefrontal cortex. Since peripheral administra-
tion of the ROCK inhibitor hydroxyfasudil has been found to be
effective in the brain in vivo, as evidenced by enhancement of
working memory [16], we used this inhibitor to evaluate the role of
ROCK in fear memory and the experience related changes in
hippocampal NRXN1/2/3a SS#3 and SS#4 splicing. Hydro-
xyfasudil is a specific Rho-kinase inhibitor and has .100-fold
greater selectivity to ROCK over other protein kinases both in
vitro and in vivo; its inhibitory effect on ROCK is 100 times
greater than on PKC and 1,000 times greater on myosin light-
chain kinase (MLCK) [17–20]. To confirm the ability of this
hydroxyfasudil to inhibit ROCK activity in vivo under the
experimental conditions we measured the amount of phosphor-
ylated cofilin, an endogenous ROCK substrate [21] in the
hippocampal tissues.
There is significant evidence for cross-talk of neurexins and
PSD-95, a family of excitatory postsynaptic scaffolding proteins
found in excitatory synapses that controls the balance between
excitatory and inhibitory synapses, and of gephyrin, a scaffolding
protein found exclusively in inhibitory synapses in contacting
dendrites [22]. Considering the role of SS#4 isoforms in the
formation of neurexins’ trans-synaptic complexes, the levels of
excitatory (PSD95) and inhibitory (gephyrin) synaptic proteins
were also assessed.
Results
Depolarization represses NRXN3a but not NRXN1a
splicing in brain cortical neurons
Cultured neurons from rat brain cortical areas expressed all
expected NRXN1a and NRXN3a splice variants at splice sites
SS#1, SS#2, SS#3 (the alternative exon E11 in NRXN3a and its
homolog E12 in NRXN1a) and SS#4 (the alternative exon E20 in
NRXN3a and its homolog E21 in NRXN1a) and the respective b
forms at SS#4 [2]. NRXN3a and NRXN1a SS#3 and SS#4
exon-included transcripts were predominant under basal condi-
tions (Figure 1).
Depolarization of the neurons (50 mM KCl, 6 hours) induced a
significant increase in NRXN3a transcript levels whereas
NRXN1a levels were unaffected (Figure 1 panel A1). There was
no evidence for an effect of depolarization on NRXN1a
alternative splicing (Figure 1 panels B1 and B2) but in NRXN3a
exon preference at both SS#3 and SS#4 shifted towards exon
exclusion (Figure 1 panels C1 and C2). Notably, splicing
repression was associated with decrease in exon included and
concomitant increase in exon excluded transcripts, relative to the
total amount of transcripts.
The time course of NRXN3a E11 and E20 splicing repression
was studied by applying the depolarizing medium (50 mM KCl)
for 6 and 12 hours and exon included transcripts were measured
using real time PCR. To examine the reversibility of this response
the depolarizing medium was applied for 6 hours and then
replaced with growth medium (5 mM KCl) and exon included
transcripts were measured for up to 12 hours afterwards. As can
be seen in Figure 2, E11 and E20 NRXN3a splicing repression
reached a maximum within 12 hours. The splicing repression was
reversible and baseline levels of the E11 and E20 NRXN3a
included transcripts were attained within 12 hours of the recovery
period.
E11 and E20 NRXN3a splicing repression depends on
RNA transcription but not de novo protein synthesis
The effects of the mRNA synthesis inhibitor actinomycin D and
of the translational inhibitor cycloheximide on the expression of
NRXN3a SS#3 and SS#4 splice variants were explored. As can
be seen in Figure 3, actinomycin D did not affect exon 11 or exon
20 included transcripts at baseline but completely abolished the
depolarization-induced decrease in both NRXN3a E11 and E20
included transcripts. Cycloheximide did not affect NRXN3a
SS#3 transcripts at baseline or the depolarization-induced E11
and E20 splicing repressions (Figure 3A and B).
The depolarization-induced E11 splicing repression is
Ca
2+ dependent and mediated via activation of PKC
pathway
The role of Ca
2+ in the depolarization-induced exclusion of E11
and E20 NRXN3a was explored using the cell-permeable
intracellular Ca
2+ chelating agent BAPTA-AM. As can be seen
in Figure 4 panels A1 and A2, BAPTA-AM (100 uM) did not
affect the amount of E11 and E20 NRXN3a included transcripts
at baseline but completely abolished the depolarization-induced
NRXN3a E11 and E20 splicing repression, as was the case with
E11 NRXN2a splicing [12].
The involvement of downstream Ca
2+ dependent pathways in
the depolarization-induced changes in NRXN2a and NRXN3a
E11 splicing was studied using pharmacological tools aimed at
activating or inhibiting the mechanisms of interest (Figure 4,
Figure 5). It was expected that inhibition of a critical component in
the downstream pathway will inhibit the depolarization-induced
splicing repression whereas activation of the pathway under basal
conditions will cause depolarization-like splicing repression in the
neurons. Incubation of primary cortical neurons for 6 hours with
the PKC inhibitor Go ¨6983 did not affect E11 and E20 NRXN3a
splicing and decreased the amount of E11 NRXN2a transcripts at
baseline (Figure 4 panels B1, B2 and D1). Go ¨6983 prevented the
depolarization-induced splicing repression of NRXN3a E11 and
E20 as well as NRXN2a E11; in the presence of this inhibitor E11
and E20 including transcripts levels were comparable to those in
non-depolarized neurons (Figure 4 panels B1, B2 and D1).
Exposure of the cortical neurons to the ubiquitous PKC activator,
phorbol 12-myristate 13-acetate (PMA;100 nM) selectively re-
duced NRXN3a E11 splicing under the basal conditions and
obviated the effects of depolarization on the splicing of this exon
Neurexins Splicing and Memory
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had no effect on NRXN3a E20 or NRXN2a splicing at baseline
and did not prevent the depolarization induced repression of these
exons (Figure 4 panels C1, C2 and D2).
Role of Rho-associated kinase (ROCK II) in NRXN2a SS#3
and NRXN3a SS#3 and SS#4 splicing repression
The involvement of the ROCK II, a downstream pathway to
PKC, in NRXN2a and NRXN3a splicing was explored (Figure 5).
Under basal conditions the ROCK II inhibitor Y27632 (10 uM)
did not affect NRXN3a E11 and E20 splicing and suppressed
NRXN2a E11 splicing. Under the high KCl conditions Y27632
prevented the depolarization induced repressions of NRXN3a
E11 and E20 as well as NRXN2a E11 splicing (Figure 5 panels
A1, A2 and A3). The involvement of ROCK II in the
depolarization-induced splicing NRXN2a SS#3 and NRXN3a
SS#3 and SS#$ splicing was further explored by the use of
lysophosphatidic acid (LPA), which activates intracellular signaling
pathways of phospholipase C (PLC)/PKC, Ras/mitogen-activated
protein (MAP)- kinase, and Rho/Rho-associated kinase [23–25].
LPA decreased the amounts of E11 including NRXN2a and
NRXN3a transcripts under low KCl, similar to the effect of
depolarization, and obviated the repression seen under depolar-
ization (Figure 5 panels B1 and B3). However, LPA was not
sufficient to promote E20 NRXN3a splicing repression under
basal (low K) conditions, nor obviate the depolarization-induced
repression of NRXN3a E20 splicing (Figure 5 panel B2).
Fear conditioning leads to E11 and E20 NRXN3a splicing
repression in the hippocampus
The effects of fear conditioning on NRXN1/2/3a splicing were
studied in rats. We first compared NRXN1/2/3a expression and
splicing in non-conditioned and conditioned animals that were
injected i.p. with vehicle (saline) or hydroxyfasudil, an hour before
Figure 1. Depolarization differentially affects NRXN1a and NRXN3a splice variants expression. (A1) Real-time PCR analysis of total
NRXN1a and NRXN3a transcripts 6 hours after treatment of primary cortical rat neurons with 5 (low K) and 50 mM (high K) KCl respective to GAPDH.
(A2) Schematic representation of alternative splicing at SS#1, SS#3 and SS#4 of NRXN1a and NRXN3a. (B1, C1) Rat cortical neurons grown in culture
for 14 days were incubated with 5 (lane 1, 3 and 5 low K) and 50 mM (lane 2, 4 and 6 high K) KCl for 6 hours. Relative quantities of exon-included
(variant 1) and -skipped (variant 2) mRNA products were measured by RT-PCR analysis with primers designed to amplify across SS#1, SS#3 and
SS#4. Representative results of NRXN1a (B1) and NRXN3a (C1) splice variants are shown in the gel panels. The bands were densitometrically
quantified using the Image J program (B2-C2). The semi-quantitative estimation of the exon-included and the exon-skipped transcripts respective to
the sum of both variants is depicted. (Values are mean +SEM from at least 3 experiments, *=P,0.05; t-test).
doi:10.1371/journal.pone.0018579.g001
Neurexins Splicing and Memory
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after the training and NRXN1/2/3a expression and alternative
splicing patterns were subsequently assessed in the hippocampus
and prefrontal cerebral cortex. No significant differences in
NRXN1a and 3a expression were noted in the hippocampus in
conditioned compared to non-conditioned animals treated with
saline (Figure 6 panels A and C) but there was an increase in
NRXN2a expression (, p=0.017 Figure 6 panel B).
Fear conditioning resulted in significant changes in NRXN1/2/
3a SS#4 splicing patterns. Thus, in the conditioned compared to
non-conditioned animals there was a significant repression of
SS#4 splicing (E20 or the respective E21 in NRXN1a)i n
NRXN1/2/3a (p=0.002, p=0.042 and p=0.002, respectively)
in the hippocampus Fig 6 panels A, B and C).
The effects of ROCK inhibition on NRXN splicing and
memory formation in vivo were studied. A main problem with
studies in vivo is the accessibility of the affected organ to the drug.
Since peripheral administration of the ROCK inhibitor hydro-
xyfasudil has been found to be effective in the brain in vivo, we
chose to use it for the in vivo experiment. Following
administration of hydroxyfasudil, i.p., one hour before the
training total NRXN3a expression tended to decrease
(p=0.051) in the conditioned animals only (Figure 6 panel C).
In addition, the ROCK inhibitor attenuated the repression of
NRXN1/2/3a SS#4 splicing in the hippocampus in the
conditioned significantly compared to non-conditioned animals
(Figure 6 panels A, B and C).
To evaluate the degree of inhibition of ROCK under the
experimental conditions we assessed the amount of cofilin and
phospho-cofilin in the hippocampi of non-conditioned and
conditioned animals sacrificed 2 hours after training (Figure 7
panels A1 and A2). The amount of cofilin as compared to
GAPDH was not affected by fear conditioning of hydroxyfasudil
administration. However, a decrease of ,50% in phospho-cofilin
was observed following hydroxyfasudil administration in non-
conditioned and even more in the conditioned animals (Figure 7
panel A2). The effect of hydroxyfasudil on phosphor-cofilin was no
longer found in the conditioned animals sacrificed 48 hours later
(Figure 7 panel B2).
Fear conditioning did not affect significantly NRXN1/2/3a
SS#3 and SS#4 splicing in the prefrontal cortex compared to
non-conditioned animals with or without hydroxyfasudil (data not
shown).
Fear conditioning leads to a ROCK independent increase
in PSD95 levels in the hippocampus
The effects of fear conditioning training on PSD95 and
gephyrin levels were assessed at 2 hours after training (Figure 8).
In the conditioned compared to non-conditioned animals PSD95
levels in the hippocampus tended to increase. The increase was
significant in hydroxyfasudil treated animals. No changes were
observed in gephyrin levels in the hippocampus at this time point.
There were no significant changes in the levels of these proteins in
the prefrontal cortex (Figure 8).
Figure 2. The depolarization-induced repression of E11 NRXN3a splicing is reversible. Real-time PCR quantification of (A1) E11 and (B1)
E20 NRXN3a included transcripts expressed in rat cortical neurons incubated with 5 and 50 mM KCl for 6 hours. Reversibility of the induced
depolarization effects on the expression of E11 and E20 NRXN3a included transcripts was monitored after 6 or 12 hours of depolarization and
following an additional recovery period of 6 or 12 hours in culture medium after KCl washout. Rq values are mean +SEM from at least 3 experiments
(*=P,0.05; t-test). (A2-B2) Schematic representation of the high KCl effects on E11 NRXN3a splicing.
doi:10.1371/journal.pone.0018579.g002
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ROCK mediated NRXN3a E20 splicing in the
hippocampus
The effects of peripheral administration of hydroxyfasudil (i.p.
injection) 1 hour before fear conditioning on the behavioral
response to tone assessed 48 hours later were assessed. The
hydroxyfasudil and saline treated groups did not differ in the mean
time needed to complete 51–75 licks prior to tone onset (tested
48 hours after training; p.0.5, Figure 9A), indicating that
hydroxyfasudil administration had no effect on animals’ uncon-
ditioned drinking. The behavioral response to tone (tested
48 hours after training) was significantly impaired in the animals
who received hydroxyfasudil prior to the training, as reflected in
the shorter times to complete 25 licks after tone onset (indicative of
lower fear) in the hydroxyfasudil treated rats compared to rats that
received saline (main treatment effect (F(1,13)=4.8, p,0.05;
Figure 9B).
The administration of hydroxyfasudil before fear conditioning
training had no effect on NRXN1/2/3a expression when
measured two hours after test, but resulted in significantly lower
splicing of E21 NRXN1a and E20 NRXN3a in the hippocampus
as compared to vehicle treated animals (p=0.038 and 0.007
respectively) and a tendency toward reduction in E20 NRXN2a
p=0.065; Figure 9C and D). No effects were observed in the
prefrontal cortex. The behavioral fear response was significantly
correlated with the amount of NRXN2a (p=0.001) and
NRXN3a (p=0.048) E20 included transcripts in the hippocampus
(measured at two hours after testing) but not with E21 NRXN1a
included transcripts (Figure 9E).
Fear conditioning memory formation is associated with
ROCK mediated -regulation PSD95 and gephyrin in the
hippocampus
Peripheral administration of hydroxyfasudil (i.p. injection)
1 hour before fear conditioning training resulted in significantly
lower levels of PSD95 and gephyrin in the hippocampus measured
at two hours after testing (i.e. 50 hours after training) as compared
to conditioned animals that were treated with saline (Figure 10 A–
D). Levels of these proteins in the prefrontal cortex were not
affected (Figure 10 B, D). There was a highly significant
correlation between the behavioral fear response and PSD95
levels in the hippocampus (p=0.015; Figure 10 E). No such
correlation was found for gephyrin. However, there was a
significant negative correlation between NRXN1a SS#4 tran-
script levels and the amount of gephyrin in the hippocampus
(p=0.015; Figure 10 E).
Discussion
Although neurexins have been known to play a role in the
synaptic excitatory-inhibitory balance, very little is known about
the dynamics of NRXN1/2/3a splicing patterns, mechanisms that
regulate them and the functional outcomes of such. We have
investigated the regulation of NRXN1/2/3a splicing in the
context of neuronal depolarization and memory formation in
adult animals. Our studies demonstrated specific and differential
effects of depolarization on NRXN3a SS#3 and SS#4 splicing in
neurons, and showed that splicing repression also occurred in vivo
in the course of training. Notably, whenever there was a repression
in the splicing, the alternative exon excluded transcript increased
and the total amounts of transcripts was not reduced and even
increased. Nevertheless, without further experiments on stability of
certain transcripts, we cannot exclude the possibility that findings
reported here may (at least in part) be due to alterations in the
stability of individual transcripts.
Further investigations on the downstream pathways mediating
the depolarization-induced changes in NRXN1/2/3a splicing
revealed a major role of the Rho/ROCK pathway in mediating
the Ca
2+ dependent E11 NRXN2a and NRXN3a as well as E20
NRXN3a splicing repression. Some PKC isoforms are activated
by calcium [26,27]. PKC can activate ROCK [28]. The PKC
inhibitor Go ¨6983 inhibited the depolarization induced E11
splicing repression. ROCK inhibition inhibited the depolariza-
tion-induced splicing repression. In principle, the PKC inhibitor
Go ¨6983 may also directly inhibit voltage dependent Ca
2+ channels
[29] thus reducing Ca
2+ entry and downstream responses.
However, PKC activation by PMA provoked NRXN3a E11
splicing repression in the brain neurons similar to depolarization.
PMA was however insufficient to provoke NRXN2a E11
NRXN3a E20 in the absence of depolarization.
The results further demonstrate a role of ROCK in mediating
the Ca
2+ dependent splicing repression at NRXN3a E11 and E20
and NRXN2a E11 in vitro and the experience related splicing of
NRXN1/2/3a SS#4 exons and memory formation in vivo. Here,
Figure 3. The depolarization-induced repression of NRXN3a
E11 and E20 splicing depends on RNA synthesis but not
protein synthesis. Rat cortical neurons grown in culture for 14 days
were incubated with 5 and 50 mM KCl for 6 hours in the absence
(control) or presence of actinomycin (10 ug/ml), cycloheximide (10 ug/
ml). Quantification of NRXN3a (A) E11 and (B) E20 included transcripts
was performed by Real-time PCR RT-PCR. Rq values are mean +SEM
from at least 3 experiments (*=P,0.05; t-test).
doi:10.1371/journal.pone.0018579.g003
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dependent repression at all 3 splice sites. In principle, the ROCK
inhibitor Y27632 may also directly inhibit PKC (Ki 26 uM).
Therefore, the effects observed with this inhibitor might in
principle reflect inhibition of PKC rather than ROCK. However,
at 10 uM which is significantly below the Ki of this inhibitor for
PKC, Y27632 is specific for the inhibition of ROCK [30].
Furthermore, activation of the PKC/ROCK pathway elicited
splicing repression of E11 in both NRXN2a and NRXN3a but
was not sufficient to repress NRXN3a E20 splicing in the absence
Figure 5. The depolarization-induced repression of E11 and E20 Splicing is mediated by ROCK II. Rat cortical neurons grown in culture
for 14 days were incubated with 5 and 50 mM KCl for 6 hours in the absence or presence of Y27632 (10 uM, panels A1 A2 and A3) or LPA (60 uM,
panels B1, B2 and B3) Real-time PCR analysis of E11 NRXN3a (panels A1 and B1), E20 NRXN3a (panels A2 and B2) and E11 NRXN2a (panels A3 and B3)
included transcripts was performed. Rq values are mean +SEM from at least 3 experiments (*=P,0.01; t-test).
doi:10.1371/journal.pone.0018579.g005
Figure 4. Involvement of Ca
2+ and PKC in E11 and E20 splicing repression. Rat cortical neurons grown in culture for 14 days were incubated
with 5 and 50 mM KCl for 6 hours in the absence or presence of BAPTA-AM (100 uM, panels A1 and A2), Go ¨6983 (1 uM; panels B1, B2, and D1) and
PMA (100 nM, panels C1, C2 and D2). Real-time PCR analysis of E11 NRXN3a (panels A1, B1,and C1) E20 NRXN3a (panels A2, B2 and C2) and E11
NRXN2a (panels D1 and D2) included transcripts was performed. Rq values are mean +SEM from at least 3 experiments (*=P,0.01; t-test).
doi:10.1371/journal.pone.0018579.g004
Neurexins Splicing and Memory
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used in vivo. This inhibitor that effectively inhibited ROCK in the
hippocampus, as indicated by the decline in phospho-cofilin, also
inhibited SS#4 exons splicing repression in the hippocampus as
well as memory formation. The IC50 (concentration needed to
attain 50% response) of hydroxyfasudil for ROCK is between 1–
Figure 6. Fear conditioning-induced NRXN1/2/3a E20 splicing repression in the hippocampus. Rats were injected with Saline or with
hydroxyfasudil (1 mg/kg) an hour prior to fear conditioning training. RNA samples from brain hippocampal area of conditioned and non-conditioned
animal groups were extracted 2 hours after the training and tested by real time PCR. (A) NRXN1a (B) NRXN2a and (C) NRXN3a expression, E11 and
E20 included transcripts levels are depicted. Rq values are mean +SEM of 7 animals/group in the non-conditioned 9 in the conditioned and 5 in the
hydroxyfasudil treated groups (*=p,0.05 t test).
doi:10.1371/journal.pone.0018579.g006
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decrease of ,50% in phospho-cofilin in non-conditioned and even
more in the conditioned animals. Provided that cofilin is only
phosphorylated via ROCK dependent pathways this would mean
that the amount of hydroxyfasudil present in the hippocampus at
2 hours after administration is approximately equal to the IC50,
namely 1–2 mM. At this concentration (and even 10 times higher
than that), hydroxyfasudil is highly specific for ROCK and does
not inhibit other potential kinases in the calcium regulated
pathways such as PKC and MLCK [18]. However, as phosphor-
ylation of cofilin is mediated by LIM kinases which are
downstream of ROCK but can also be activated by other
pathways, it is possible that the level of hydroxyfasudil in the
hippocamapal cells was in fact higher than estimated. Therefore
the possibility that additional pathways might have also contrib-
uted to the observed effects, cannot be excluded. The inhibition of
the splicing repression by hydroxyfasudil is thus ROCK specific. It
may thus be concluded that while the hydroxyfasudil-inhibited
pathway is necessary and sufficient for E11 splicing repression, it is
necessary but not sufficient to elicit the response at SS#4 in the
absence of stimulation.
There is a great deal of parallelism between the Rho/ROCK
pathway and the neurexins system. Both are involved in
exocytosis, neuronal differentiation during development cognitive
performances and mental retardation [31–41]. Our observation
on ROCK-dependent changes in neurexins splicing in the course
of memory formation may thus shed light on this apparent
parallelism between ROCK activation, the neurexins system and
memory formation.
Despite high structural similarities of the respective splice sites,
both in vitro and in vivo experiments have demonstrated differential
splicing patterns of the 3 NRXN1/2/3a in response to activation.
Whereas depolarization of brain neurons resulted in SS#3 splicing
repression in NRXN2a [12] and NRXN3a,S S #3 splicing in
Figure 7. Peripheral Administration of Hydroxyfasudil reduces Phospho-Cofilin Levels in the Hippocampus. Rats were injected with
Saline or with hydroxyfasudil (1 mg/kg) an hour prior to fear conditioning training. Conditioned and non-conditioned animals were sacrificed 2 hours
after the training (panels A1 and B1) or 48 hours afterwards (panels B1 and B2) and the content of cofilin, phosphocofilin and gapdh were assessed
by immunoblot in samples from the brain hippocampal area using specific antibodies. (A1-B1) Representative immunoblots of the proteins in the
hippocampus. (A2-B2) The levels of phosphocofilin (P-Cofilin) relative to gapdh are depicted in panels A2 and B2. Values are mean +SEM, *=p,0.05 t
test; n=3 for the non-conditioned and n=5 for the conditioned groups).
doi:10.1371/journal.pone.0018579.g007
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activation resulted in suppression of SS#4 splicing exclusively at
NRXN3a, in vivo there was a repression of SS#4 splicing in all
three NRXN1/2/3a transcripts in the hippocampus after the
training. A possible explanation for the differences in the results
from cultured neurons and intact brain is that NRXN1/2/3a
SS#4 splicing repression in vivo requires the involvement of
additional cell types (glia, astrocytes, etc) or extracellular factors
that are absent in the neuronal culture. It is also possible, taking
into consideration that the splicing repression is reversible and has
different kinetics for different splice sites in the different neurexins,
that the picture observed at a certain time point reflects the
temporary state. These options remain to be investigated.
The onset and recovery rates of the splicing repression also
differ between the neurexins and was faster for NRXN2a SS#3
(E11) (6 hours; [12]) than NRXN3a (12 hours). Results in vivo are
essentially compatible with a dynamic response. Thus, the
experience related suppression in SS#4 splicing (in all three
NRXN1/2/3a transcripts) was observed at 2 hours after the
training and apparently reversed later on, as found at 2 hours after
the testing. The differential effects of activation on SS#3 and
SS#4 splicing in the 3 NRXN1/2/3a and the differences in
respective onset and recovery rates strongly suggest a role of more
than one factor, beside ROCK, in the alternative splicing of the
various NRXN1/2/3a gene products.
The dynamics of the splicing repressions is compatible with a
role of the particular transcripts in intermediate steps in synaptic
remodeling. It is interesting to note that while NRXN1/2/3a
SS#4 splicing was repressed after training it was the reversal of
this process (i.e., the recovery in NRXN2a and NRXN3a E20
exon-included transcripts in the hippocampus) that correlated with
the behavioral fear response. One explanation for the transient
nature of the splicing repression is transfer of the memory traces
from the hippocampus to other brain networks for memory
consolidation. For hippocampus-dependent tasks, memory storage
occurs first in the hippocampus and over time is transferred to
cortical areas (for review, see [42]). We did not observe differences
in NRXN1/2/3a expression and splicing in the prefrontal cortex
in the conditioned animals but cannot rule out this possibility
because such changes might be limited to certain areas or may not
be involved in the long term memory consolidation.
Onemayarguethatthereversalofthesplicing repressionisrelated
to memory retrieval inthe behavioral testing. Retrieval triggers a time
interval when the original memory becomes labile or extinct [43].
However, the significant correlation between the spliced NRXN2a
and NRXN3a SS#4 transcripts and behavior suggest that the
Figure 8. Fear conditioning effects on PSD95 and gephyrin levels in the hippocampus and prefrontal cortex. Hippocampus and
Prefrontal Cortex protein samples from rats injected with saline or hydroxyfasudil (1 mg/kg) were extracted 2 hours following fear conditioning
training and tested by immunoblotting. (A) PSD95 levels in the hippocampus; (B) Representative immunoblot of PSD95 in the proteins samples from
the hippocampus and prefrontal cortex; (C) Gephyrin levels in the hippocampus; (D) Representative immunoblot of gephyrin in the proteins samples
from the hippocampus and prefrontal cortex. Values are mean +SEM of 3 animals/group in the non-conditioned and 5 in the conditioned group
(*=p,0.05 t test).
doi:10.1371/journal.pone.0018579.g008
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memory. Furthermore, the levelsof PSD95 inthe hippocampus were
reported positively correlated with the behavioral fear response.
Elevated levels of PSD-95 alter the ratio of excitatory to inhibitory
synaptic contacts by sequestering members of the neuroligins family
to excitatory synapses [44]. Considering the role of SS#4i nt h e
differential binding of NRXN1/2/3 to neuroligins, LRRTM2 and
Cbln1- GluRd2, it is possible that the changes in NRXN1/2/3a
SS#4 splicing during fear conditioning promoted changes in trans-
synaptic interactions of the neurexins polymorphs, and subsequently
Figure 9. Fear conditioning is attenuated in hydroxyfasudil-treated rats. Rats were injected with hydroxyfasudil (1 mg/kg.) or saline 1 hour
before fear conditioning. Memory performance was tested 48 hours afterwards and animals were sacrificed 2 hours later and NRXN1/2/3a expression
and splicing assessed by Real Time PCR. (A) Mean6SEM times to complete 25 licks prior to tone onset. (B) Mean6SEM times (logarithmically
transformed) to complete 25 licks in the presence of a tone that was previously paired with shock in saline and hydroxyfasudil-treated rats.
Hydroxyfasudil reduced fear conditioning as manifested in shorter lick time after tone onset compared to controls. *=significant difference (p,0.05)
between the treated and the control groups. (C) NRXN1/2/3a expression (D) NRXN1/2/3a E20/E21 transcript levels. (E) Significant correlations
between the behavioral response and the amount of E21 NRXN1a and E20 NRXN2a and NRXN3a included transcripts in the hippocampus. Values are
mean +SEM of 7 animals per group (*p,0.05).
doi:10.1371/journal.pone.0018579.g009
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formation. Specific neurexins’ transcripts may thus be involved in
synaptic remodeling occurring at an intermediate (hours) timescalein
the course of memory formation.
On the other hand, lower gephyrin levels were inversely
correlated with NRXN1a splicing and neither correlated with
behavioral fear response. Previous studies have demonstrated that
gephyrin mRNA and protein levels are upregulated after
extinction training [45,46]. Alpha-neurexins promote clustering
of the gephyrin, as well as GABAA receptor and neuroligin 2 at
GABA-ergic synapses in a LNS6 domain dependent mode (where
E20 is localized) [22]. It cannot be rules out that activation of
ROCK in the course of fear conditioning training elicits the
change in SS#4 NRXN1a splicing and the reversal of this effect
subsequent changes in gephyrin levels are triggered by the testing
and linked to the memory retrieval process.
Figure 10. Fear Conditioning Effects on PSD95 and gephyrin levels in the hippocampus and prefrontal cortex. Rats were injected with
hydroxyfasudil (1 mg/kg.) or vehicle 1 hour before fear conditioning training. Memory performance was tested 48 hours afterwards and animals were
sacrificed 2 hours later. Protein samples were then prepared from the hippocampus and prefrontal cortex and assessed by immunoblotting. (A)
PSD95 levels in the hippocampus; (B) Representative immunoblot of PSD95 in the proteins samples from the hippocampus and prefrontal cortex; (C)
Gephyrin levels in the hippocampus; (D) Representative immunoblot of gephyrin in the proteins samples from the hippocampus and prefrontal
cortex. (E) Significant correlations between the behavioral response and the amount of PSD95 (F) Significant correlations between E21 NRXN1a and
the amount of gephyrin in the hippocampus. Values are Mean6SEM of 7 animals per group (*p,0.05).
doi:10.1371/journal.pone.0018579.g010
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experience related changes in NRXN1/2/3a alternative splicing
in the course of memory formation. In this respect the data
provide a new insight into the normal processing of memory traces
by showing that the behavioral response is associated with an
initial suppression but also requires subsequent recovery of SS#4
splicing. It remains to be further examined whether the splicing
suppression results in loss or decrease in certain trans-synaptic
complexes, to allow subsequent remodeling.
Materials and Methods
Materials
Minimal essential medium (MEM), Dulbecco’s modification of
Earle’s medium (DMEM), heat-inactivated horse serum (IHS), L-
glutamine, penicillin-streptomycin and EZ-RNA Total RNA
Isolation Kit were purchased from Biological Industries (BI, Beit
Haemek, Israel), B-27 supplement from Invitrogen (Carlsbad,
CA), Verso
TM RT-PCR System from Thermo Scientific, Taq
DNA polymerase from Bioline (Luckenwalde, Germany) and
KAPA SYBER FAST qPCR Kit from KapaBiosystems (Woburn,
MA). All other inhibitors and activators were purchased from
Sigma (Sigma-Aldrich, St. Louis, MO). Anti PSD95, gephyrin and
gapdh antibodies were from Abcam, Cambridge, MA) and anti
cofilin and phospho-cofilin antibodies from Cell Signaling
Technology (Danvers MA).
Animals
All experimental protocols conformed to the animal care
guidelines of the National Institutes of Health (NIH) and approved
by the Institutional Animal Care and Use Committee (animal
welfare approval numbers A5010-01 and L-05-032).
Cell culture and treatment
Cultures were prepared from postnatal day 1 Sprague-Dawley
rats. Cortical tissue was digested with papain (100 U; 20 min)
triturated to a single-cell suspension. Cells were plated onto 6 wells
plates (2610
6 cells/plate) precoated with 100 mg/ml poly-L-lysine
in MEM containing 5% IHS, 2% B-27 neuronal supplement, and
100 IU/ml of penicillin, 100 mg/ml of streptomycin, 2 mM
glutamine and 6 mg/ml D-Glucose. Cells grown for 11–13 days
in culture were incubated with 50 (‘‘high K’’) or 5 mM (‘‘low K’’)
KCl in growth medium at 37uC in humidified atmosphere with
5% CO2 for 6 hours (found in optimization studies to ensure a
fully developed response). RNA was extracted using EZ-RNA
Total RNA Isolation Kit.
Fear conditioning and drug injection
Adult (350–400 g) male Wistar rats were housed 3–4 to a cage
under reversed cycle lighting (lightson: 1900–0700 h) withad libfood
and water, unless otherwise described. Fear conditioning was assessed
in a thirst-motivated conditioned emotional response (CER)
procedure, conducted in standard rodent test chambers equipped
with a retractable bottle and a drinkometer (Campden Instruments,
United Kingdom). The experimental protocol conformed to the
guidelines of the Institutional Animal Care and Use Committee of
Tel Aviv University, Israel, and to the guidelines of the NIH (animal
welfare assurance number A5010-01, expires on 9.30.2011).
Thirty two adult (350–400 g) male Wistar rats participated in
the experiment. They were housed 3–4 per cage under reversed
cycle lighting (lights on: 1900–0700 h) with ad lib food and water.
A 22 h water restriction schedule was initiated 10 days prior to the
beginning of the experimental procedure. Handling (2 min/day)
was initiated simultaneously with water restriction and continued
for 5 days. On the next 5 days, rats were trained to drink in the
experimental chamber for 20 min/day. Water in the test
apparatus was given in addition to the daily ration of 2 hours
given in the home cages. Fear conditioning procedure was
conducted on days 11–14 as follows: On day 11, with the bottle
removed, all animals were given 30 min habituation to the
apparatus. Conditioning and drug injection were conducted 24 h
later. One hour prior to the beginning of conditioning 16 rats
received a single intraperitoneal (i.p.) injection of hydroxyfasudil
(Hydroxyfasudil; 1.0 mg/kg in saline; Sigma, St Louis USA), and
16 rats) received an equivalent volume of saline (Saline). With the
bottle removed, each rat was put into the chambers for 20 min.
Thirteen rats from each drug condition received fear conditioning,
consisting of 2 tone (10 s, 80 dB, 2.8 kHz)-shock (0.5 mA, 1 s)
pairings, with shock immediately following tone termination, given
5 min apart (conditioned). The first pairing was given 5 min after
placement in the box and rats were taken out 5 min after the
second pairing. The 3 remaining rats from each drug condition
rats were merely confined to the chamber for an identical period of
time (non-conditioned). Two hours after the conditioning stage,
the 6 non-conditioned (3 Saline and 3 Hydroxyfasudil), and 10
conditioned (5 Saline and 5 Hydroxyfasudil) rats, were sacrificed.
The remaining 16 conditioned rats (8 Saline and 8 Hydroxyfa-
sudil) were tested 48 hours later to assess their level of fear to the
tone. Each rat was placed in the chamber with an access to the
bottle. When the rat completed 75 licks, the tone was presented.
Times to complete 25 licks prior to tone onset (licks 51–75) and
after tone onset (licks 76–100) were recorded. Each rat was
sacrificed 2 hours after the test session.
Tissue dissecting, RNA and protein extraction
The brains were rapidly removed, frozen on dry ice and kept at
270uC. Tissue was then homogenizing and the RNA and proteins
extracted using the NucleoSpinH RNA/Protein kit (Macherey-
Nagel, GmbH & Co KG, Du ¨ren, Germany).
RNA extraction and reverse transcription
Total RNA (1.5 mg) was denatured in the presence of a specific
primer or oligo-dT for 10 min at 70uC. cDNA was then prepared
(1 h at 42uC) using Verso
TM RT-PCR System from Thermo
Scientific. Reactions were blocked by 3 minutes incubation at
95uC and samples stored at 220uC.
PCR amplification and DNA sequencing
cDNA sample aliquots were added to reaction mixtures
containing 1.5 mM MgCl2, 200 mM dNTP, 500 nM of each
primer and 1 U Taq DNA polymerase. Amplification reactions
(PTC-200 thermal cycler) started with denaturation phase (3 min
at 94uC) followed by repeated cycles of incubations (30 s at 94uC,
30 s at 62uC and 30 s at 72uC). PCR products were subjected to
electrophoresis on 2.5% agarose gel and stained with ethidium
bromide [10 mg/ml]. Gels were photographed on top of a 280 nm
UV light box and images densitometrically quantified with the PC
Image J program. RT-PCR analysis was performed with primers
designed to amplify across splice sites SS#1, 3 and 4 in NRXN1a
and NRXN3a as shown in Table 1. RT-PCR values are presented
as a ratio of the NRXN1a or 3a splice variant’s signal in the
selected linear amplification cycle divided by the total NRXN1a
or 3a signal (sum of all variants) respectively. The resultant value
was expressed as arbitrary units. To compare between different
experiments, these values were calculated as % of the respective
value for the exon included splice variant in control cells treated
with low K.
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The primers used for real time PCR analysis are depicted in
Table 2. Gene expression values for the various NRXN1/2/3a and
splice variants were calculated based on the comparative threshold
cycle(Ct) method[47].Ctvalueswerecorrectedfor100%efficiency
as described [48] according to the following formula: Ct E=100%=
Ct E { log (1+E)/log (2)}; where E=10
-1/slope.
The corrected Ct data for a specific NRXN isoform, total
NRXN mRNA and the housekeeping gene GAPDH mRNA in
each sample were used to create DCt values for total NRXN in
sample (Ct total NRXN –C tGAPDH) and specific isoform transcripts
(Ct specific NRXN isoform –C ttotal NRXN). Thereafter, DDCt values
were calculated by subtracting the DCt of the untreated control
sample from the Ct value of treated sample. Rq=2
2DDCt.
Immunoblotting
The protein samples (25 mg) were subjected to SDS-PAGE and
immunoblotting. Blots were blocked with blocking buffer (5% non-
fat dry milk in PBS or 0.1% BSA) for 1 hour at room temperature.
Blots were subjected to the primary antibody (PSD95 1:500,
gephyrin 1:500, gapdh 1:1000 cofilin 1:700, phospho-cofilin 1:700)
in PBS with 0.1% Tween 20 (PBST) overnight at 4uC. Blots were
washed with PBST (4610 min each) at room temperature on a
bench top shaker. Secondary antibodies conjugated to IRDye 800
or IRDye 680 (Li-cor) were diluted 1:10000 in PBST. The
membranes were incubated with the fluorescently-labeled second-
ary antibodies for 1 hour at room temperature in the dark on a
bench top shaker. The membranes were washed in PBST
(4610 min each) at room temperature in the dark on a bench
top shaker and then briefly rinsed in PBS. Membranes were
scanned and analyzed using an Odyssey IR scanner using Odyssey
imaging software 3.0. (Li-cor). Scan settings were medium or high
image quality, 160 mm resolution and intensity 3.0–5.0 for both
channels. Antibody signals were analyzed as integrated intensities
of regions defined around the band of interest in either channel.
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